-
3
-
-
48249151316
-
-
Talecris; Health Canada endorsed safety information on Gamunex® 10%. [cited 2007 July 30] Available from: URL
-
Talecris; Health Canada endorsed safety information on Gamunex® 10%. [cited 2007 July 30] Available from: URL: http://www.hc-sc.gc.ca/dhp-mps/medeff/ advisories-avis/prof/2005/gamunex_nth-aah_e.html.
-
-
-
-
4
-
-
33745180204
-
Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG)
-
Coghill J, Comeau T, Shea T, Braddy L, Bandarenko N, Afenyi-Annan A, Harvey D. Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG). Biol Blood Marrow Transplant 2006 12 : 786 8.
-
(2006)
Biol Blood Marrow Transplant
, vol.12
, pp. 786-8
-
-
Coghill, J.1
Comeau, T.2
Shea, T.3
Braddy, L.4
Bandarenko, N.5
Afenyi-Annan, A.6
Harvey, D.7
-
5
-
-
0030803022
-
Hemolytic anemia associated with intravenous immunoglobulin
-
Wilson JR, Bhoopalam N, Fisher M. Hemolytic anemia associated with intravenous immunoglobulin. Muscle Nerve 1997 20 : 1142 5.
-
(1997)
Muscle Nerve
, vol.20
, pp. 1142-5
-
-
Wilson, J.R.1
Bhoopalam, N.2
Fisher, M.3
-
6
-
-
0026528532
-
Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease
-
Comenzo RL, Malachowski ME, Meissner HC, Fulton DR, Berkman EM. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease. J Pediatr 1992 120 : 926 8.
-
(1992)
J Pediatr
, vol.120
, pp. 926-8
-
-
Comenzo, R.L.1
Malachowski, M.E.2
Meissner, H.C.3
Fulton, D.R.4
Berkman, E.M.5
-
7
-
-
0027145629
-
Hemolysis after high-dose intravenous Ig
-
Thomas MJ, Misbah SA, Chapel HM, Jones M, Elrington G, Newsom-Davis J. Hemolysis after high-dose intravenous Ig. Blood 1993 82 : 3789.
-
(1993)
Blood
, vol.82
, pp. 3789
-
-
Thomas, M.J.1
Misbah, S.A.2
Chapel, H.M.3
Jones, M.4
Elrington, G.5
Newsom-Davis, J.6
-
8
-
-
15444354107
-
-
European Pharmacopoeia, supplement 5.6 to the5th edition. June 29: Sections 2.6.20.
-
Human normal immunoglobulin for intravenous administration. European Pharmacopoeia, supplement 5.6 to the 5th edition. 2006 : June 29: Sections 2.6.20.
-
(2006)
Human Normal Immunoglobulin for Intravenous Administration
-
-
-
9
-
-
20444412706
-
Soluble type a substance in fresh frozen plasma as a function of ABO and secretor genotypes and Lewis phenotype
-
Achermann FJ, Julmy F, Gilliver LG, Carrel TP, Nydegger UE. Soluble type A substance in fresh frozen plasma as a function of ABO and secretor genotypes and Lewis phenotype. Transfus Apher Sci 2005 32 : 255 62.
-
(2005)
Transfus Apher Sci
, vol.32
, pp. 255-62
-
-
Achermann, F.J.1
Julmy, F.2
Gilliver, L.G.3
Carrel, T.P.4
Nydegger, U.E.5
-
10
-
-
0031821633
-
Immune complex-like moieties in immunoglobulin for intravenous use (IVIg) bind complement and enhance phagocytosis of human erythrocytes
-
Shoham-Kessary H, Naot Y, Gershon H. Immune complex-like moieties in immunoglobulin for intravenous use (IVIg) bind complement and enhance phagocytosis of human erythrocytes. Clin Exp Immunol 1998 113 : 77 84.
-
(1998)
Clin Exp Immunol
, vol.113
, pp. 77-84
-
-
Shoham-Kessary, H.1
Naot, Y.2
Gershon, H.3
-
11
-
-
84882458798
-
Transfusion-related acute lung injury
-
In: Hillyer, C.D., Silberstein, L.E., Ness, P.M., Anderson, K.C., Roback, J.D., editors. ed. Churchill Livingstone. p.
-
Webert KE, Kleinman SH, Blajchman MA. Transfusion-related acute lung injury. In : Hillyer CD, Silberstein LE, Ness PM, Anderson KC, Roback JD, editors. Blood banking and transfusion medicine. 2nd ed. Churchill Livingstone 2007. p. 694.
-
(2007)
Blood Banking and Transfusion Medicine. 2nd
, pp. 694
-
-
Webert, K.E.1
Kleinman, S.H.2
Blajchman, M.A.3
|